Total Funding
33
78
Total FundingSeed raised
Growth Score 33 in past quarter
-4 pts
Heat Score 78 in past quarter
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
59291
Halodine is a biopharmaceutical company focused on development of novel antiviral therapies.
- Kara Capriotti: Co-Founder and Vice President Clinical Science
About the Company
Halodine is a biopharmaceutical company focused on the development of novel antiviral therapies.
Halodine is a proprietary povidone-iodine antiseptic developed by leading clinicians for repeated nasal and oral administration. Halodine Nasal Antiseptic and Halodine Oral Rinse have been proven effective against SARS-CoV-2, the virus causing
COVID-19, as well as other infections. Safe and easy-to-use, Halodine is designed to help protect hospitalized patients, health care personnel, and consumers.
It was founded and is led by practicing MDs. Founded in 2020, the company is based in Miami, Florida.
Women Founded